|
Essential oils and contraindications in palliative careIn addition to the normal local and general contraindications for the use of essential oils and massage, the following cautions have been compiled from the resources listed below. IMPORTANT: This does not mean that Therapists cannot use these oils, but extra care and a good rationale for treatment and an appropriate level of skill and route of delivery is required. CancerBalacs and Tisserand (1995) suggest avoiding the following essential oils for cancer:
(p229) Oestrogen-dependent cancers avoid anethole-high oils (Zondek 1938 p645, Albert-Puelo 1980 p344)
and citral high oils (Geldof 1992 p144) such as:
(Buckle 1997 p78 and 135) MelanomasAvoid:
(Buckle 1997 p86) Oils high in d-limonene (citrus oils such as sweet orange, lime, lemon and grapefruit) have been shown to stimulate tumerous growths in mice on the site of topical application (Roe 1959 p92-93; Roe et al. 1960, p1403; Peirce 1961 p497-498; Elegbede 1986 p2049). Renal diseasesAvoid:
(Balacs et al. 1995 p231)
(Price et al. 1999 p328) Hepatic diseaseAvoid:
(Balacs et al.1995 p231) and
(Buckle 1997 p84) Cardiac diseaseAvoid:
(Balacs et al. 1995 p234) Interactions with medicationMost adverse interactions with conventional medications are associated with the oral use of essential oils. However, Sweet birch and wintergreen are contraindicated for Warfarin (Balacs et al. 1995, p43). Poor storage and degrading oilsd-limonene high oils (citrus oils) in particular will quickly degrade after opening to produce weak carcinogenic chemicals (Homberger et al. 1968 p2372) or will increase risk of sensitisation and skin irritation. Therefore the shelf life of opened bottles if stored correctly is recommended to be 1 year, or 2 years of stored in a fridge. Citrus oils will last 6 months if stored correctly. Contraindications for massageThere is no evidence to suggest that massage is contraindicated for cancer patients (Price et al. 1999 p247) except for the following circumstances in addition to normal local and general contraindications for massage: Avoid:
Damaged skin (including eczema and psoriasis)
Balacs et al. 1995 p229 Purchasing, supply and labellingOils should not be used unless purchased form an Aromatherapy Trade Council (ATC - the UK regulatory body for the essential oil trade) approved supplier to ensure quality and to ensure against adulteration. Essential oils come under UK Health and Safety legislation - COSHH (Control of Substances Hazardous to health) and CHIP (Chemicals: Hazardous Information and Packaging for Supply) therefore should be stored properly with controlled access with appropriate risk assessments in place (Buckle 1997 p95). The above regulations will enable Clinical Managers to make informed decisions about the appropriate use of particular essential oils and to identify potential for risk. Essential oil dealers should provide Material Data Sheets listing the chemical CAS number, chemical data, toxicity and other hazardous information. Correct labelling should conform to CHIP 1994 regulations, include include the name of the supplier, essential oil common name, botanical name, expiry date, batch number and CHIP hazardous warnings. PractitionersThe advice given to Primary care practitioners wishing to refer their patients to a Complementary Therapist recommend that they seek a Therapist with an Aromatherapy Organisations Council (AOC) recognised qualification (Department of Health 7:1). Individual practitioners have an obligation of a duty of care according to their own code of practice. ManagersClinical managers are responsible for introducing and implementing an Aromatherapy and Essential Oil Policy with appropriate regard to Health and Safety legislation with protocols for staff training (Buckle 1997 p95). Restricted essential OilsThe following are oils which are on (International Fragrance Accociation (IFRA) restricted list and should be used with caution: Angelica root oil Angelica archangelica (phototoxic)
0.78% Banned IFRA essential oil listCade oil crude Juniperus oxycedrus (carcinogen) Additional list for discussion: the following oils
are also under discussion for safety: (Burfield 2001 RQA Conference) Safe oilsBelow is a list of essential oils which are safe to use in normal dilution with no known contraindications compiled from using all the literature included in the references below:
ReferencesAlbert-Puelo M (1980) Fennel and anise as estrogenic agents. Journal of Ethnopharmacology 2: 337-344 Balacs T, Tisserand R (1995) Essential Oil Safety: A Guide for Health Care Professionals. London: Churchill Livingstone Buckle J (1997) Clinical Aromatherapy in Nursing. London: Arnold Publishers Burfield T (2001) RQA AGM 11th March 2001 London : Safety address Elegbede J A (1986) Mouse skin tumour activity of orange peel oil and d-limonene: a re-evaluation. Carcinogenesis 7:12 2047-2049 Department of Health (2000) Complementary medicine: Information pack for Primary Care Groups June 2000 7:1 Geldof A A (1992) Estrogenic action of commonly used fragrant agent citral induces prostatic hyperplasia. Urological Research 20: 139-144 Homberger F, Boger E (1968) The carcinogenicity of essential oils, flavours and spices: a review. Cancer Research 28: 2372-2374 McNamara P (1993) Massage for people with cancer: a working paper. London: Wansdworth cancer Support Centre Publication Peirce W (1961) Tumour-promotion by lime oil in the mouse forestomach. Nature 189: 497-498 Roe F (1959) Oil of sweet orange: a possible role in carcinogenesis. British Journal of Cancer 13:92-93 Roe F, Peirce W (1960) Tumour promotion by citrus oils. Journal of the National Cancer Institute 24: 1389-1403 Zondek B (1938) Phenol methyl esters as estrogenic agents. Biochemical Journal 32: 641-645 InformationAromatherapy Organisations Council - AOC (the major umbrella
organisation to ensure quality in training and practice. AOC membership organisations
Aromatherapy Trade Council (the regulatory body
for the UK essential oil trade) |
|
© Jane Ellwood |